Europe Veterinary Healthcare Market Growth, Size, Trends, Revenue, Demand and Future Outlook

Europe Veterinary Healthcare Market Size- By Product, By Animal Type- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Europe Veterinary Healthcare Market Size- By Product, By Animal Type- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: Feb 2024 Report ID: HLCA2422 Pages: 1 - 159 Formats*:     
Category : Healthcare
Europe Veterinary Healthcare Market Introduction and Overview 

According to SPER Market Research, the Europe Veterinary Healthcare Market is estimated to reach USD 21.62 billion by 2033 with a CAGR of 7.8%.

The report includes an in-depth analysis of the Europe Veterinary Healthcare Market, including market size and trends, product mix, distribution channels, and supplier analysis. The term "veterinary healthcare" describes the medical attention and services given to animals, especially domestic pets and livestock, with the goal of ensuring their health and welfare. It covers a broad spectrum of procedures and therapies meant to avoid, identify, and manage diseases, wounds, and other medical issues in animals. Through routine vaccinations, parasite control, dental care, nutrition counseling, and wellness check-ups, it involves steps to prevent illnesses and maintain the general health of animals. Additionally, by addressing animal abuse or neglect, advocating for humane treatment, and guaranteeing the wellbeing of animals in various settings, veterinary healthcare professionals also play a critical role in promoting animal welfare.

  • VolitionRx launched its Nu. Q Vet Cancer Screening Test in the United States and Europe in November 2022, using Heska's veterinary diagnostic laboratories as its global supply partner.
  • The Livestock Vaccination Guideline was launched in May 2022 by the United Kingdom National Office of Animal Health (NOAH) to assist veterinarians and farmers in improving the health and welfare of sheep and cattle in the United Kingdom, as well as to support farm resilience and sustainable productivity improvements.
Europe Veterinary Healthcare Market
Market Opportunities and Challenges

Opportunities: The primary factor driving the European veterinary healthcare market is rising animal adoption in European countries, combined with increased government initiatives and improved animal healthcare. According to the Pet Food Manufacturers Association, 3.2 million UK households had acquired a pet since the pandemic began in 2021. The UK has 34 million pets, which include 12 million cats, 12 million dogs, 3.2 million small mammals such as guinea pigs and hamsters, 3 million birds, and 1.5 million reptiles. Furthermore, technological advancements in animal diagnostic technologies for accurate diagnostics, as well as increased penetration by some of the market's key and dominant players, are expected to drive market growth. 

Challenges: Numerous issues affect the dynamics and general efficacy of the European veterinary healthcare market. The rising incidence of zoonotic illnesses, or infections spread from animals to humans, is one major problem. This calls for sophisticated and specialized care, placing pressure on veterinary healthcare systems to keep up with new illnesses and implement efficient preventative measures. Financial difficulties are also faced by pet owners and healthcare professionals due to the rising expense of veterinary care and the growing demand for pet insurance. Moreover, differences in standards, licensing, and approval procedures for veterinary medications and therapies are a result of regulatory complexities among European nations, which impedes the smooth integration of markets. The market's fragmented structure, which includes a large number of small and medium-sized businesses, presents additional difficulties for effective distribution networks and streamlined operations.

Europe Veterinary Healthcare Market


Market Competitive Landscape
The existence of multiple companies operating both globally and regionally has resulted in fragmentation within the European veterinary healthcare market. Among the well-known and market-share-holding companies analyzed in the competitive landscape are Abaxis Inc., Bayer AG, Benfield Pet Hospital, Boehringer Ingelheim International GmbH, Ceva Animal Health Inc., CVS Group, ECO Animal Health, Elanco, Greencross Vets, Idexx Laboratories, MSD Animal Health, The Bergh Memorial Animal Hospital, Vetoquinol UK Limited, Virbac, and Zoetis Animal Healthcare.

Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2033
 Base year considered 2022
 Forecast period 2023-2033
 Segments coveredBy Product, By Animal Type
 Regions covered
Germany, United Kingdom, France, Italy, Spain, Rest of Europe

 Companies CoveredBoehringer Ingelheim International GmbH, Ceva Sante Animale (CEVA), Dechra Pharmaceuticals PLC., Dopharma, ECO Animal Health Group Plc, Elanco, Hipra, Idexx Laboratories, Inc., Laboratorios Syva, MSD Animal Health, Norbrook, Orion Corporation, Vetoquinol S.A., Virbac, Others.
COVID-19 Impact on Europe Veterinary Healthcare Market
The European pandemic caused supply chain disruptions and delays in the delivery of diagnostic equipment, consumables, and reagents, which initially had a negative effect on the market during COVID-19. The market faced a number of major challenges during a pandemic, such as port checkpoints and truck traffic jams that slowed down the delivery of essential supplies; several nations imposed export bans; and only a small number of manufacturing facilities were operational. Consequently, at first, these factors hindered the market's growth rate. Conversely, the pandemic's outbreak led to a rise in pet ownership in Spain, which helped the market expand.

Key Target Audience:
  • Veterinarians and Veterinary Practitioners
  • Pet Owners and Animal Enthusiasts
  • Animal Farm Owners and Livestock Producers
  • Pharmaceutical and Biotechnology Companies
  • Retailers and Distributors
Our in-depth analysis of the Europe Veterinary Healthcare Market includes the following segments:
By Product:
  • Therapeutics
  • Diagnostics
  • By Animal Type:
  • Dogs and Cats
  • Horses
  • Ruminants
  • Swine
  • Poultry
  • Others
  • By Region:
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Key Topics Covered in the Report:
    • Europe Veterinary Healthcare Market Size (FY’2023-FY’2033)
    • Overview of Europe Veterinary Healthcare Market
    • Segmentation of Europe Veterinary Healthcare Market By Product (Therapeutics, Diagnostics)
    • Segmentation of Europe Veterinary Healthcare Market By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, Others)
    • Expansion Analysis of Europe Veterinary Healthcare Market
    • Problems and Obstacles in Europe Veterinary Healthcare Market
    • Competitive Landscape in the Europe Veterinary Healthcare Market
    • Impact of COVID-19 and Demonetization on Europe Veterinary Healthcare Market
    • Details on Current Investment in Europe Veterinary Healthcare Market
    • Competitive Analysis of Europe Veterinary Healthcare Market
    • Prominent Players in the Europe Veterinary Healthcare Market
    • SWOT Analysis of Europe Veterinary Healthcare Market
    • Europe Veterinary Healthcare Market Future Outlook and Projections (FY’2023-FY’2033)
    • Recommendations from Analyst
    1. Introduction
    1.1. Scope of the report
    1.2. Market segment analysis

    2. Research Methodology
    2.1. Research data source
    2.1.1. Secondary Data
    2.1.2. Primary Data
    2.1.3. SPER’s internal database
    2.1.4. Premium insight from KOL’s
    2.2. Market size estimation
    2.2.1. Top-down and Bottom-up approach
    2.3. Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.1.4. Challenges
    4.2. COVID-19 Impacts of the Europe Veterinary Healthcare Market

    5. Market variable and outlook
    5.1. SWOT Analysis
    5.1.1. Strengths
    5.1.2. Weaknesses
    5.1.3. Opportunities
    5.1.4. Threats
    5.2. PESTEL Analysis
    5.2.1. Political Landscape
    5.2.2. Economic Landscape
    5.2.3. Social Landscape
    5.2.4. Technological Landscape
    5.2.5. Environmental Landscape
    5.2.6. Legal Landscape
    5.3. PORTER’s Five Forces 
    5.3.1. Bargaining power of suppliers
    5.3.2. Bargaining power of buyers
    5.3.3. Threat of Substitute
    5.3.4. Threat of new entrant
    5.3.5. Competitive rivalry
    5.4. Heat Map Analysis

    6. Competitive Landscape
    6.1. Europe Veterinary Healthcare Market Manufacturing Base Distribution, Sales Area, Product Type 
    6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Veterinary Healthcare Market 

    7. Europe Veterinary Healthcare Market, By Product (USD Million)
    7.1. Europe Veterinary Healthcare Market Value Share and Forecast, By Product, 2023-2033
    7.2. Therapeutics
    7.2.1. Vaccines
    7.2.2. Parasiticides
    7.2.3. Anti-infectives
    7.2.4. Medical Feed Additives
    7.2.5. Others
    7.3. Diagnostics
    7.3.1. Immunodiagnostic Tests
    7.3.2. Molecular Diagnostics
    7.3.3. Diagnostic Imaging
    7.3.4. Clinical Chemistry
    7.3.5. Others

    8. Europe Veterinary Healthcare Market, By Animal Type (USD Million)
    8.1. Europe Veterinary Healthcare Market Value Share and Forecast, By Animal Type, 2023-2033
    8.2. Dogs and Cats
    8.3. Horses
    8.4. Ruminants
    8.5. Swine
    8.6. Poultry
    8.7. Others

    9. Europe Veterinary Healthcare Market Forecast, 2019-2033 (USD Million)
    9.1. Europe Veterinary Healthcare Market Size and Market Share

    10. Europe Veterinary Healthcare Market, By Product, 2019-2033 (USD Million)
    10.1. Europe Veterinary Healthcare Market Size and Market Share By Product (2019-2026)
    10.2. Europe Veterinary Healthcare Market Size and Market Share By Product (2027-2033)

    11. Europe Veterinary Healthcare Market, By Animal Type, 2019-2033 (USD Million)
    11.1. Europe Veterinary Healthcare Market Size and Market Share By Animal Type, (2019-2026)
    11.2. Europe Veterinary Healthcare Market Size and Market Share By Animal Type, (2027-2033)

    12. Europe Veterinary Healthcare Market, By Region, 2019-2033 (USD Million)
    12.1. Europe Veterinary Healthcare Market Size and Market Share By Region (2019-2026)
    12.2. Europe Veterinary Healthcare Market Size and Market Share By Region (2027-2033)
    12.3. Germany
    12.4. United Kingdom
    12.5. France
    12.6. Italy
    12.7. Spain
    12.8. Rest of Europe

    13.  Company Profile
    13.1. Boehringer Ingelheim International GmbH
    13.1.1. Company details
    13.1.2. Financial outlook
    13.1.3. Product summary 
    13.1.4. Recent developments
    13.2. Ceva Sante Animale (CEVA)
    13.2.1. Company details
    13.2.2. Financial outlook
    13.2.3. Product summary 
    13.2.4. Recent developments
    13.3. Dechra Pharmaceuticals PLC.
    13.3.1. Company details
    13.3.2. Financial outlook
    13.3.3. Product summary 
    13.3.4. Recent developments
    13.4. Dopharma
    13.4.1. Company details
    13.4.2. Financial outlook
    13.4.3. Product summary 
    13.4.4. Recent developments
    13.5. ECO Animal Health Group Plc
    13.5.1. Company details
    13.5.2. Financial outlook
    13.5.3. Product summary 
    13.5.4. Recent developments
    13.6. Elanco
    13.6.1. Company details
    13.6.2. Financial outlook
    13.6.3. Product summary 
    13.6.4. Recent developments
    13.7. Hipra
    13.7.1. Company details
    13.7.2. Financial outlook
    13.7.3. Product summary 
    13.7.4. Recent developments
    13.8. Idexx Laboratories, Inc.
    13.8.1. Company details
    13.8.2. Financial outlook
    13.8.3. Product summary 
    13.8.4. Recent developments
    13.9. Laboratorios Syva
    13.9.1. Company details
    13.9.2. Financial outlook
    13.9.3. Product summary 
    13.9.4. Recent developments
    13.10. MSD Animal Health
    13.10.1. Company details
    13.10.2. Financial outlook
    13.10.3. Product summary 
    13.10.4. Recent developments
    13.11. Norbrook
    13.11.1. Company details
    13.11.2. Financial outlook
    13.11.3. Product summary 
    13.11.4. Recent developments
    13.12. Orion Corporation
    13.12.1. Company details
    13.12.2. Financial outlook
    13.12.3. Product summary 
    13.12.4. Recent developments
    13.13. Vetoquinol S.A.
    13.13.1. Company details
    13.13.2. Financial outlook
    13.13.3. Product summary 
    13.13.4. Recent developments
    13.14. Virbac
    13.14.1. Company details
    13.14.2. Financial outlook
    13.14.3. Product summary 
    13.14.4. Recent developments
    13.15. Others

    14. Reference Links

    15. Conclusion

    16. Research Scope 

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    Europe Veterinary Healthcare Market is projected to reach USD 21.62 billion by 2033, growing at a CAGR of 7.8% during the forecast period.
    Europe Veterinary Healthcare Market size from 2022. The Market is expected to reach USD 21.62 billion by 2033, at a CAGR of 7.8% during the forecast period.
    Europe Veterinary Healthcare Market CAGR of 7.8% during the forecast period.
    Europe Veterinary Healthcare Market size is 21.62 billion from 2023 to 2033.
    Europe Veterinary Healthcare Market Segment is covered By Product, By Animal Type.
    The Europe is anticipated to have the highest market share in the Europe Veterinary Healthcare Market.
    "The key players in the market include Companies Covered Boehringer Ingelheim International GmbH, Ceva Sante Animale (CEVA), Dechra Pharmaceuticals PLC., Dopharma, ECO Animal Health Group Plc, Elanco, Hipra, Idexx Laboratories, Inc., Laboratorios Syva, MSD Animal Health, Norbrook, Orion Corporation, Vetoquinol S.A., Virbac, Others."
    Furthermore, technological advancements in animal diagnostic technologies for accurate diagnostics, as well as increased penetration by some of the market's key and dominant players, are expected to drive market growth.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here
    PLACE AN ORDER
    • 15% off
       
      $ 3400
    • 20% off
               
      $ 4520
    • 25% off
           
      $ 5650
    Pre-Purchase Inquiry
    SEND AN INQUIRY
    NEED CUSTOMIZATION?
    Request Customization
    CALL OR EMAIL US
    US:
    India:
    Email:
    100% Secure Payment

    SPER American Express
    SPER VISA
    SPER Master Card
    SPER Mestro
    SPER Paypal
    SPER CCAvenues

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650